In this study, we demonstrated that soluble factors produced by prostate cancer increase basal calcium as well as the proportion of cells with active fluctuations in calcium levels in RANKL-primed osteoclast precursors. The gene discussed is TNFSF11; the disease is Familial prostate cancer.